Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Approach to insomnia in patients with dementia.

Molano J, Vaughn BV.

Neurol Clin Pract. 2014 Feb;4(1):7-15. doi: 10.1212/CPJ.0b013e3182a78edf.

2.

The Black Book of Psychotropic Dosing and Monitoring.

Schatzberg AF, Charles D.

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. No abstract available.

PMID:
29382960
3.

Reward-Related Ventral Striatum Activity Buffers against the Experience of Depressive Symptoms Associated with Sleep Disturbances.

Avinun R, Nevo A, Knodt AR, Elliott ML, Radtke SR, Brigidi BD, Hariri AR.

J Neurosci. 2017 Oct 4;37(40):9724-9729. doi: 10.1523/JNEUROSCI.1734-17.2017. Epub 2017 Sep 18.

4.

Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.

Donovan LM, Rise PJ, Carson SS, Feemster LC, Griffith MF, Kapur VK, Krishnan JA, Lindenauer PK, Mularski RA, Naureckas ET, Palen BN, Parsons EC, Spece LJ, Vitiello MV, Au DH; CONCERT Investigators.

Ann Am Thorac Soc. 2017 Dec;14(12):1836-1843. doi: 10.1513/AnnalsATS.201706-453OC.

PMID:
28825846
5.

Genetic and Environmental Influences on Sleep, Pain, and Depression Symptoms in a Community Sample of Twins.

Gasperi M, Herbert M, Schur E, Buchwald D, Afari N.

Psychosom Med. 2017 Jul/Aug;79(6):646-654. doi: 10.1097/PSY.0000000000000456.

PMID:
28658193
6.

Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors.

Benham RS, Hewage NB, Suckow RF, Engin E, Rudolph U.

Behav Brain Res. 2017 Aug 14;332:172-179. doi: 10.1016/j.bbr.2017.05.063. Epub 2017 Jun 3. Erratum in: Behav Brain Res. 2018 Feb 15;338:186-189.

PMID:
28587819
7.

Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.

Edinger JD, Manber R, Buysse DJ, Krystal AD, Thase ME, Gehrman P, Fairholme CP, Luther J, Wisniewski S.

J Clin Sleep Med. 2017 Feb 15;13(2):205-213. doi: 10.5664/jcsm.6448.

8.

Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.

McCall WV, Benca RM, Rosenquist PB, Riley MA, McCloud L, Newman JC, Case D, Rumble M, Krystal AD.

Am J Psychiatry. 2017 Jan 1;174(1):18-25. doi: 10.1176/appi.ajp.2016.16030336. Epub 2016 Sep 9. Review.

9.

An Update on the Use of Sedative-Hypnotic Medications in Psychiatric Disorders.

Creado S, Plante DT.

Curr Psychiatry Rep. 2016 Sep;18(9):78. doi: 10.1007/s11920-016-0717-y. Review.

10.

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Kripke DF.

F1000Res. 2016 May 19;5:918. doi: 10.12688/f1000research.8729.1. eCollection 2016. Review.

11.

Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial.

Morin CM, Edinger JD, Krystal AD, Buysse DJ, Beaulieu-Bonneau S, Ivers H.

Trials. 2016 Mar 3;17(1):118. doi: 10.1186/s13063-016-1242-3.

12.

Association Between Specific Depression Symptoms and Glycemic Control Among Patients With Comorbid Type 2 Diabetes and Provisional Depression.

Czech SJ, Orsillo SM, Pirraglia PA, English TM, Connell AJ.

Prim Care Companion CNS Disord. 2015 Oct 15;17(5). doi: 10.4088/PCC.14m01754. eCollection 2015.

13.

Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians.

Asnis GM, Thomas M, Henderson MA.

Int J Mol Sci. 2015 Dec 30;17(1). pii: E50. doi: 10.3390/ijms17010050. Review.

14.
15.

Reduced Sleep Spindles in Schizophrenia: A Treatable Endophenotype That Links Risk Genes to Impaired Cognition?

Manoach DS, Pan JQ, Purcell SM, Stickgold R.

Biol Psychiatry. 2016 Oct 15;80(8):599-608. doi: 10.1016/j.biopsych.2015.10.003. Epub 2015 Oct 14. Review.

16.

The Effect of Sleep Disturbances on Major Depressive Disorder.

Pigeon WR.

Depress Mind Body. 2009;4(3):102-110.

17.

Neural Reward Processing Mediates the Relationship between Insomnia Symptoms and Depression in Adolescence.

Casement MD, Keenan KE, Hipwell AE, Guyer AE, Forbes EE.

Sleep. 2016 Feb 1;39(2):439-47. doi: 10.5665/sleep.5460.

18.

Pharmacological approaches to the challenge of treatment-resistant depression.

Ionescu DF, Rosenbaum JF, Alpert JE.

Dialogues Clin Neurosci. 2015 Jun;17(2):111-26. Review.

19.

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.

Rethorst CD, Greer TL, Toups MS, Bernstein I, Carmody TJ, Trivedi MH.

Transl Psychiatry. 2015 Aug 4;5:e611. doi: 10.1038/tp.2015.104. Review.

Supplemental Content

Support Center